Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new 'vascular triad'

被引:37
作者
Lip, GYH [1 ]
Blann, AD [1 ]
机构
[1] Univ Birmingham, Dept Med, City Hosp, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
关键词
angiogenesis; atherogenesis; thrombogenesis; vascular disease;
D O I
10.1080/07853890310021607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amongst the components of the pathophysiology of atherosclerosis are the tendency to thrombus formation (i.e., thrombogenesis) and the loss of endothelial cell integrity The endothelium is also implicated in atherogenesis, as vasal vasorum are present in the adventitia and media at a higher density in atherosclerotic tissue, and that neovascularisation leading to collateral growth bypassing obstruction and/or stenoses provides important alternative routes to feeding distal tissues. The development of these new blood vessels is the process of angiogenesis. The present 'viewpoint' article will explore the relationships between the three processes. There is considerable evidence that atherogenesis and thrombogenesis are intimately linked, but angiogenesis in cardiovascular disease is a recently developed concept. We propose a new 'vascular triad' of these abnormal pathophysiological processes, leading to an alternative view of the pathogenesis of vascular disease. Indeed, we suggest that angiogenesis is an important aspect of the pathophysiology of cardiovascular disease, impacting with both thrombogenesis and atherogenesis, in a new vascular triad (the 'Birmingham vascular triad').
引用
收藏
页码:119 / 125
页数:7
相关论文
共 58 条
[11]   Vascular endothelial growth factor and its receptor, Flt-l, in the plasma of patients with coronary or peripheral atherosclerosis, or type II diabetes [J].
Blann, AD ;
Belgore, FM ;
McCollum, CN ;
Silverman, S ;
Lip, PL ;
Lip, GYH .
CLINICAL SCIENCE, 2002, 102 (02) :187-194
[12]   Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? [J].
Blann, AD .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (07) :623-630
[13]  
Boissel JP, 1999, EUR HEART J SUPPL, V1, pA1
[14]   Cooperation between VEGF and TNF-α is necessary for exposure of active tissue factor on the surface of human endothelial cells [J].
Camera, M ;
Giesen, PLA ;
Fallon, J ;
Aufiero, BM ;
Taubman, M ;
Tremoli, E ;
Nemerson, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :531-537
[15]   Vascular endothelial growth factor enhances atherosclerotic plaque progression [J].
Celletti, FL ;
Waugh, JM ;
Amabile, PG ;
Brendolan, A ;
Hilfiker, PR ;
Dake, MD .
NATURE MEDICINE, 2001, 7 (04) :425-429
[16]   Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization [J].
Chae, JK ;
Kim, I ;
Lim, ST ;
Chung, MJ ;
Kim, WH ;
Kim, HG ;
Ko, JK ;
Koh, GY .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (12) :2573-2578
[17]   Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor? [J].
Chung, NAY ;
Belgore, F ;
Hee, FLLS ;
Conway, DSG ;
Blann, AD ;
Lip, GYH .
STROKE, 2002, 33 (09) :2187-2191
[18]  
Cines DB, 1998, BLOOD, V91, P3527
[19]  
Couffinhal T, 1997, AM J PATHOL, V150, P1673
[20]   Therapeutic angiogenesis: a step forward in intermittent claudication [J].
Donnelly, R ;
Yeung, JMC .
LANCET, 2002, 359 (9323) :2048-2050